Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001493152-26-050455·Eton Pharmaceuticals, Inc.
Schedule 13G ownership disclosure
Eton Pharmaceuticals Inc
Common Stock, par value $0.001 per share · CUSIP: 29772L108
Event date: 2026-09-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Opaleye Management Inc.
Shares: 2,440,000.00 · Class: 8.54%
- Opaleye, L.P.
Shares: 2,420,000.00 · Class: 8.47%
- Silverman James
Shares: 2,440,000.00 · Class: 8.54%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001493152-26-050455
- Form type
- SCHEDULE 13G/A
- Filer
- Eton Pharmaceuticals, Inc.
- CIK
- CIK 1710340
- Filed
- Nov 06, 2026
- Reporting period
- Sep 30, 2026
- Description
- Schedule 13G beneficial ownership